Logo image
Sign in
Back
Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia
Journal article   Peer reviewed

Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia

E. Huschart, H. Miller, D. Salzberg, C. Campbell, K. Beebe, C. Schwalbach, K. Magee, R.H. Adams and A. Ngwube
Pediatric Hematology and Oncology, Vol.38(2)
2020
DOI: https://doi.org/10.1080/08880018.2020.1829220

Abstract

alanine aminotransferase aspartate aminotransferase azacitidine bilirubin hemoglobin antineoplastic antimetabolite azacitidine, acute myeloid leukemia Article child childhood leukemia chronic graft versus host disease clinical article cytopenia disease free survival donor lymphocyte infusion drug dose reduction drug safety drug tolerability feasibility study female flow cytometry graft versus host reaction hematopoietic stem cell transplantation high risk patient human leukemia remission low drug dose maintenance therapy male minimal residual disease multiple cycle treatment myeloablative conditioning retrospective study side effect acute myeloid leukemia adolescent hematopoietic stem cell transplantation infant lymphocyte transfusion preschool child procedures transplantation conditioning, Adolescent Antimetabolites, Antineoplastic Azacitidine Child Child, Preschool Female Hematopoietic Stem Cell Transplantation Humans Infant Leukemia, Myeloid, Acute Lymphocyte Transfusion Male Transplantation Conditioning

Metrics

1 Record Views

Details